Metraipolis › archive › dc_09eb6c42ae55

Current Perspectives on STING Agonists for Anticancer Drug Development — Europe PMC PMID:42503996

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42503996
DOI
10.1111/cbdd.70370
License (as archived)
solo-consultazione
Archived
2026-10-18T13:50:35.785Z
SHA-256 of the archived text
3db22286a685e712e11fd675655d2bf9e52cafd8eb8c8d9f1113aa761b934d5e
Stable URL of this page
https://metraipolis.com/documento/dc_09eb6c42ae55

How to cite

Current Perspectives on STING Agonists for Anticancer Drug Development — Europe PMC PMID:42503996 — Europe PMC (en), https://europepmc.org/article/MED/42503996 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09eb6c42ae55 (Metraipolis archive dc_09eb6c42ae55, sha256 3db22286a685e712e11fd675655d2bf9e52cafd8eb8c8d9f1113aa761b934d5e)
BibTeX
@misc{dc09eb6c42ae55,
  title = {Current Perspectives on STING Agonists for Anticancer Drug Development — Europe PMC PMID:42503996},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42503996},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09eb6c42ae55; sha256 3db22286a685e712e11fd675655d2bf9e52cafd8eb8c8d9f1113aa761b934d5e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42503996. Agents can read the archived copy with the MCP tool read_document.